We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$5.68M -$2.42M -211,737 -32%
EI
52
EAM Investors
California
$5.36M +$4.87M +425,718 New
Franklin Resources
53
Franklin Resources
California
$5.22M +$3.67M +320,528 +341%
Prudential Financial
54
Prudential Financial
New Jersey
$5.12M -$8.48M -740,821 -65%
SBH
55
Segall Bryant & Hamill
Illinois
$4.94M -$45.7K -3,992 -1%
Russell Investments Group
56
Russell Investments Group
United Kingdom
$4.93M -$1.79M -156,673 -29%
AG
57
Algert Global
California
$4.81M -$6.5M -568,299 -60%
Fidelity Investments
58
Fidelity Investments
Massachusetts
$4.75M +$955K +83,453 +28%
Barclays
59
Barclays
United Kingdom
$4.55M +$190K +16,639 +5%
Mariner
60
Mariner
Kansas
$4.35M -$571K -49,897 -13%
SPS
61
Susquehanna Portfolio Strategies
Pennsylvania
$4.13M – – –
Swiss National Bank
62
Swiss National Bank
Switzerland
$3.9M +$67.5K +5,900 +2%
Two Sigma Investments
63
Two Sigma Investments
New York
$3.79M +$2.65M +231,494 +333%
Citigroup
64
Citigroup
New York
$3.53M -$27.3K -2,384 -0.8%
UBS AM
65
UBS AM
Illinois
$3.06M +$106K +9,238 +4%
JF
66
Jump Financial
Illinois
$2.98M -$780K -68,202 -22%
Envestnet Asset Management
67
Envestnet Asset Management
Illinois
$2.96M +$855K +74,705 +47%
JCIA
68
Jackson Creek Investment Advisors
Colorado
$2.8M -$119K -10,358 -4%
Credit Agricole
69
Credit Agricole
France
$2.7M +$2.45M +214,287 New
MAM
70
Martingale Asset Management
Massachusetts
$2.64M +$110K +9,643 +5%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$2.53M -$359K -31,357 -14%
LSV Asset Management
72
LSV Asset Management
Illinois
$2.49M – – –
Stifel Financial
73
Stifel Financial
Missouri
$2.37M -$21.2K -1,852 -1%
Mackenzie Financial
74
Mackenzie Financial
Ontario, Canada
$2.34M -$160K -13,998 -7%
PP
75
PDT Partners
New York
$2.28M – – –
1 2
3
4 5

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.